Literature DB >> 2788131

The structure of HLA-B35 suggests that it is derived from HLA-Bw58 by two genetic mechanisms.

T Ooba1, H Hayashi, S Karaki, M Tanabe, K Kano, M Takiguchi.   

Abstract

The primary structure of HLA-B51 and HLA-Bw52 suggested that HLA-B51 was derived from HLA-Bw52 by the combination of a genetic exchange with HLA-B8 and a point mutation. To investigate the evolution of the HLA-B5 cross reactive group, the HLA-B35 gene was cloned and the primary structure was determined. HLA-B35 is identical to HLA-Bw58 except in the alpha 1 domain. The alpha 1 domain of HLA-B35 except Bw4/Bw6-associated amino acids is identical to that of HLA-B51, which was suspected to be an intermediate gene between HLA-B51 and HLA-Bw52. These data suggest that HLA-B35 has evolved from HLA-Bw58 in two steps; an in vivo replacement of the alpha 1 domain with HLA-B51 and genetic exchange with one of the HLA-Bw6 genes. These three genes and HLA-Bw58 are postulated to share a common ancestor. As HLA class I molecules of a serologically cross-reactive group (CREG) have limited polymorphism, we suspected they might have evolved from a common ancestor. In fact, the structures of HLA-B51 and HLA-Bw52 in HLA-B5 CREG demonstrate that they differ by only two amino acids. Both substitutions are in the helical region of the alpha 1 domain and suggest that HLA-B51 could be derived from HLA-Bw52 by the combination of a genetic exchange with HLA-B8 and a point mutation (Hayashi et al. 1989). HLA-B35 belongs to the HLA-B5 CREG and is serologically related to Bw6, while HLA-B5 (B51 and Bw52) is related to Bw4. HLA-B35 is serologically closer to HLA-B51 than to HLA-Bw52. Therefore, we have cloned a genomic gene of HLA-B35 and determined its structure to study further the evolution of the HLA-B5 family.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2788131     DOI: 10.1007/bf02421534

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  15 in total

1.  The complete primary structure of HLA-Bw58.

Authors:  J P Ways; H L Coppin; P Parham
Journal:  J Biol Chem       Date:  1985-10-05       Impact factor: 5.157

2.  Biochemical transfer of single-copy eucaryotic genes using total cellular DNA as donor.

Authors:  M Wigler; A Pellicer; S Silverstein; R Axel
Journal:  Cell       Date:  1978-07       Impact factor: 41.582

3.  Transfection of murine LMTK- cells with purified HLA class I genes. VII. Association of allele- and locus-specific serological reactivities with respectively the first and second domains of the HLA-B7 molecule.

Authors:  R Sodoyer; B Kahn-Perles; T Strachan; J Sire; M J Santoni; C Layet; P Ferrier; B R Jordan; F A Lemonnier
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

4.  Epitope mapping of HLA-B27 and HLA-B7 antigens by using intradomain recombinants.

Authors:  A Toubert; C Raffoux; J Boretto; J Sire; R Sodoyer; S R Thurau; B Amor; J Colombani; F A Lemonnier; B R Jordan
Journal:  J Immunol       Date:  1988-10-01       Impact factor: 5.422

5.  Site-directed mutagenesis of an HLA-A3 gene identifies amino acid 152 as crucial for major-histocompatibility-complex-restricted and alloreactive cytotoxic-T-lymphocyte recognition.

Authors:  E P Cowan; M L Jelachich; J E Coligan; W E Biddison
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

6.  Nature of polymorphism in HLA-A, -B, and -C molecules.

Authors:  P Parham; C E Lomen; D A Lawlor; J P Ways; N Holmes; H L Coppin; R D Salter; A M Wan; P D Ennis
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

7.  HLA-B51 and HLA-Bw52 differ by only two amino acids which are in the helical region of the alpha 1 domain.

Authors:  H Hayashi; P D Ennis; H Ariga; R D Salter; P Parham; K Kano; M Takiguchi
Journal:  J Immunol       Date:  1989-01-01       Impact factor: 5.422

8.  Primary structure of papain-solubilized human histocompatibility antigen HLA-B40 (-Bw60). An outline of alloantigenic determinants.

Authors:  J López de Castro; R Bragado; D M Strong; J L Strominger
Journal:  Biochemistry       Date:  1983-08-02       Impact factor: 3.162

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Identification by site-directed mutagenesis of amino acid residues contributing to serologic and CTL-defined epitope differences between HLA-A2.1 and HLA-A2.3.

Authors:  K T Hogan; C Clayberger; E J Bernhard; S F Walk; J P Ridge; P Parham; A M Krensky; V H Engelhard
Journal:  J Immunol       Date:  1988-10-01       Impact factor: 5.422

View more
  14 in total

1.  Patterns of nucleotide substitutions inferred from the phylogenies of the class I major histocompatibility complex genes.

Authors:  T Imanishi; T Gojobori
Journal:  J Mol Evol       Date:  1992-09       Impact factor: 2.395

2.  Allospecificities between HLA-Bw53 and HLA-B35 are generated by substitution of the residues associated with HLA-Bw4/Bw6 public epitopes.

Authors:  H Hayashi; T Ooba; S Nakayama; M Sekimata; K Kano; M Takiguchi
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

3.  Two amino acid substitutions at residues 63 and 67 between HLA-B51 and HLA-Bw52 form multiple epitopes recognized by allogeneic T cells.

Authors:  J Yamamoto; M Hiraiwa; H Hayashi; M Tanabe; K Kano; M Takiguchi
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

4.  Different rates of HLA class I molecule assembly which are determined by amino acid sequence in the alpha 2 domain.

Authors:  A Hill; M Takiguchi; A McMichael
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

5.  Binding of nonamer peptides to three HLA-B51 molecules which differ by a single amino acid substitution in the A-pocket.

Authors:  A Kikuchi; T Sakaguchi; K Miwa; Y Takamiya; H G Rammensee; Y Kaneko; M Takiguchi
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

6.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1989-11-25       Impact factor: 16.971

7.  Nomenclature for factors of the HLA system, 1989. The WHO Nomenclature Committee.

Authors: 
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

8.  Serological demonstration of HLA-Bw4/Bw6 epitopes on hybrid molecules between HLA-B35 and HLA-B51.

Authors:  M Sekimata; H Hayashi; S Nakayama; K Kano; M Takiguchi
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

9.  HLA-B alleles of the Cayapa of Ecuador: new B39 and B15 alleles.

Authors:  T L Garber; L M Butler; E A Trachtenberg; H A Erlich; O Rickards; G De Stefano; D I Watkins
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

10.  Human memory cytotoxic T-lymphocyte (CTL) responses to Hantaan virus infection: identification of virus-specific and cross-reactive CD8(+) CTL epitopes on nucleocapsid protein.

Authors:  H L Van Epps; C S Schmaljohn; F A Ennis
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.